Non-Phosphorylated Tau as a potential biomarker of Alzheimer's Disease: Analytical and diagnostic characterization

Manuscript Number: 

16-0448R2

Author(s): 
Kaj Blennow, Sebastian Brandner, Davide Chiasserini, Sebastiaan Engelborghs, Katharina Flach, Max Holzer, Johannes Kornhuber, Ingolf Lachmann, Natalia Lelental, Piotr Lewczuk, Juan Manuel Maler, José-Luis Molinuevo, Barbara Mroczko, Lucilla Parnetti, Armand Perret-Liaudet, Julius Popp, Philipp Spitzer, Charlotte E. Teunissen, Henrik Zetterberg

Disclosures

Kaj Blennow

  • Consulting Fees:
    Eli Lilly, Fujirebio Europe, IBL International, Novartis, Roch Diagnostics

Sebastian Brandner

  • Nothing to Disclose

Davide Chiasserini

  • Nothing to Disclose

Sebastiaan Engelborghs

  • Consulting Fees:
    Consulting fees or paid advisory boards: Innogenetics / Fujirebio Europe, Lundbeck, Pfizer, Novartis, UCB, Roche diagnostics, Nutricia / Danone, Eli Lilly.
    Grants
    • Agency: 
      Janssen Pharmaceutica NV and ADx Neurosciences
      Dates: 
      01 SEP 2015 - ONG

Katharina Flach

  • Sponsors:
    AJ Roboscreen GmbH
    Patents/Royalties
    joint inventor of patent number WO002016041553A2 for 1G2 owned by AJ Roboscreen GmbH

Max Holzer

  • Patents/Royalties
    joint inventor of patent number WO002016041553A2 for 1G2 owned by AJ Roboscreen GmbH

Johannes Kornhuber

  • Nothing to Disclose

Ingolf Lachmann

  • Sponsors:
    employed by AJ Roboscreen GmbH
    Patents/Royalties
    joint inventor of patent number WO002016041553A2 for 1G2 owned by AJ Roboscreen GmbH

Natalia Lelental

  • Nothing to Disclose

Piotr Lewczuk

  • Consulting Fees:
    PL received consultation honoraria from Innogenetics, AJ Roboscreen GmbH, Roche, and Virion\Serion GmbH, and is a member of the scientific advisory board for IBL International GmbH, Hamburg. This study was supported by AJ Roboscreen, Leipzig, Germany, and IBL International GmbH, Hamburg, Germany.
    Patents/Royalties
    PL is a joint inventor of the patent number WO002016041553A2 for 1G2 owned by AJ Roboscreen GmbH.

Juan Manuel Maler

  • Nothing to Disclose

José-Luis Molinuevo

  • Consulting Fees:
    I am a member of the following diagnostic advisory boards: IBL, Roche diagnostics, Raman Health technologies

Barbara Mroczko

  • Lecture Fees:
    I received consultation and/or lectures honoraria from Cormay and Roche. T

Lucilla Parnetti

  • Nothing to Disclose

Armand Perret-Liaudet

  • Patents/Royalties
    I am joint inventor of patent number WO002016041553A2 for 1G2 owned by AJ Roboscreen GmbH

Julius Popp

  • Nothing to Disclose

Philipp Spitzer

  • Nothing to Disclose

Charlotte E. Teunissen

  • Consulting Fees:
    Roche
    Lecture Fees:
    Axon Neuroscience, Roche
    Grants
    • Agency: 
      Roche
      Dates: 
      2016

Henrik Zetterberg

  • Nothing to Disclose